SUPPLEMENTARY TABLES

Supplementary
this study pACTIIstop-Sec63-2 this study pACTIIstop-H2-Sec63-2 this study pACTIIstop-H2-Sec63-2 library and plasmids isolated (Table 1) this study pBTM116
Fromont-Racine et al., 1997 pBTM116-PRP2 this study pBTM116-PRP16 this study pBTM116-PRP22 this study pBTM116-PRP43 this study pBTM116-prp16-L335F
this study pBTM116-prp16-K379R
this study pBTM116-prp16-D473E
this study pBTM116-prp16-H476D
this study pBTM116-prp16-T507A
this study pBTM116-prp16-Q685H
this study pBTM116-prp16-R686Q this study pBTM116-prp16-R686I this study pBTM116-prp16-302 this study
Shuffle plasmids
pRS316-BRR2 this study pRS315-BRR2 this study pRS315-brr2-R1107P this study pRS315-brr2-R1899G this study pRS315-brr2- K1925R0 this study pRS315-brr2-L1883P this study pRS315-brr2-L1930P this study pRS315-brr2-A1932P this study pRS315-brr2-L1951P this study pRS315- brr2-I2071T  this study  pRS315-brr2-I2073N  this study  pRS315-brr2-S2148P  this study  pRS316-BRR2/PRP16  this study  pRS314-PRP16  this study  pRS314-prp16-D473E  this study  pRS314-prp16-Q685H  this study  pRS314-prp16-R686I this study
E. coli expression plasmids
pDONR223 (entry vector) Invitrogen pET22b-PRP16-His P. Fabrizio pET22b-prp16-K379A-His this study pET22b-prp16-DE473-4AA-His this study pET22b-prp16-R686I-His this study pETM11-His-Sec2 V. Pena pETM11-His-Sec63-2 R1899G this study pET21a-PRP2-His P. Fabrizio Supplementary Table S3 List of oligonucleotides used for RT-qPCR experiments Name sequence Shaded lines indicate genes whose products are involved in pre-mRNA splicing.
Supplementary
ACT1 (Lariat + Lariat-Exon2) F AGGGGCTTGAAATTTGGAAAAA ACT1 (Lariat + Lariat-Exon2) R GCAAGCGCTAGAACATACATAGTACA ACT1 (Pre-mRNA) F AGGGGCTTGAAATTTGGAAAAA ACT1 (Pre-mRNA) R GCAACAAAAAGAATGAAGCAATCG ACT1 (Pre-mRNA + Lariat-Exon2) F TTGCTTCATTCTTTTTGTTGCT ACT1 (Pre-mRNA + Lariat-Exon2) R GCAAAACCGGCTTTACACAT ACT1 (mRNA) F TCGAAAATTTACTGAATTAACAATGGA ACT1 (mRNA) R GCAAAACCGGCTTTACACAT ACT1 (Exon2) F GCTGCTTTGGTTATTGATAACGGTTC ACT1 (Exon2) R GATGGGAAGACAGCACGAGGAG Supplementary
SUPPLEMENTARY FIGURES
Supplementary Figure S1 . Yeast-two hybrid screen to isolate brr2-Sec63-2 mutants that have altered interaction with Prp2p and/or Prp16p. Two mutant phenotypes were selected based on their growth properties on selective media. Screens with Prp16 and Prp2 baits were carried out consecutively (the images shown serve as an example). A library of brr2-H2-Sec63-2 two-hybrid constructs, randomly mutated across the Sec63-2 domain was co-transformed with the bait plasmid. Transformants were spotted to a master-plate, then replica-plated onto selective media. Mutations with stronger Y2H interactions (in green squares) exhibit resistance to higher concentrations of 3-AT (up to 65 mM for Prp16p; up to 20 mM for Prp2p) than the WT. Mutations causing weaker Y2H interactions (circled in red) display a loss of growth in the absence of histidine at 30°C but not at 14°C (most also show reduced or no resistance to 3-AT).
Supplementary Figure S2 . Sec63-2 mutations in the structure of Brr2, and in vivo phenotypes.
A. Left: Location of the Sec63-2 mutations within the structure of the carboxy-terminal helicase module of Brr2 (based on human Brr2 structure, PDB: 4F91). Structure was drawn using PyMol software. Helicase domain H2 is colored in brown, the WH2 domain is grey, the amino-terminal helical domain of Sec63-2 is pink, the middle helical domain is red and the fibronectin-3 like domain is green. Positions of single mutations isolated in the screens are highlighted in black (weaker interaction) or blue (stronger interaction , with the brr2-L1930P or brr2-L1951P allele as bait. The relative growth rates of double-deletion strains are represented as a scatter plot, in which mutations that caused synthetic growth inhibition in combination with both brr2 alleles lie on the diagonal in the lower-left quadrant. Only LIN1 and SNU66, which encode protein components of the U5 snRNP and U4/U6.U5 snRNP complex respectively (and therefore are in close physical association with Brr2p), showed a stronger genetic interaction than did ISY1. B. Deletion of ISY1 exacerbates phenotypes of brr2 mutants. The slow-growth defect of brr2 mutants with substitutions in Sec63 -2 combined with isy1Δ was confirmed on YPDA plates and increased heat sensitivity was observed at 33°C and 37°C. 
SUPPLEMENTARY MATERIALS AND METHODS
Cloning procedures
Brr2p domains H2-Sec63-2 and Sec63-2 were PCR-amplified and cloned into pBlueScript using SpeI and XhoI restriction sites. Brr2 H2 was PCR amplified from pBS-H2-Sec63-2. Subcloning in pACTII-stop was done by amplifying the coding sequence of BRR2 domains from pBS vectors using oligonucleotides carrying the desired restriction sites. LexA-bait fusions with the ORFs of PRP2, PRP16, PRP22 and PRP43 were generated by InFusion cloning (Takara). Gal4AD-prey fusions for H2-Sec63-2, H2 and Sec63-2 were constructed in pACTII-stop by standard cloning using XmaI / BamHI restriction sites. Mutations in PRP2 and PRP16 were introduced following the Quick Change protocol (Promega).
Plasmid shuffle and growth assay
A W303 brr2∆ strain was constructed by replacing one chromosomal copy of BRR2 with the kanMX6 cassette in W303 2n (1). The heterozygous deletion was confirmed by Colony PCR. The URA3 marked plasmid pRS316-BRR2 was introduced and brr2∆ haploids (W303 brr2∆) were isolated after sporulation and tetrad dissection. A plasmid -shuffling approach was used to observe the phenotypes of brr2 mutants (2) . The wild-type BRR2 gene including -276 nt 5' flanking sequence and +229 nt 3' flanking sequence was PCR amplified and cloned into a SacI / XmaI digested pRS315 backbone to create pRS315-BRR2. Mutant derivatives of pRS315-BRR2 were generated by site-directed mutagenesis (Quick Change, Promega). Plasmids used are listed in Table S1 . For growth assays overnight cultures of 5-FOA selected transformants were spotted on YPDA agar. Plates were incubated for 2 days at 25°, 30°, 37° or for 5 days at 18° or 15°. The ISY1 ORF was replaced with the natNT2 cassette (3) in W303 brr2∆ to construct W303 brr2∆/isy1∆. W303 brr2∆/prp16∆ was constructed by replacing one genomic copy of PRP16 with the natNT2 cassette in a diploid, heterozygous brr2∆ background. Growth was supported by the URA3 marked plasmid pRS316-BRR2/PRP16, expressing Brr2p and Prp16p. After sporulation and tetrad dissection brr2∆/prp16∆ haploids were selected (W303 brr2∆/prp16∆). pRS314-PRP16 was generated by cloning the PRP16 ORF including -304 nt 5' flanking sequence and +170 nt 3' flanking sequence into the XmaI site of pRS314. Mutant derivatives were constructed by site-directed mutagenesis. W303 brr2∆/prp16∆ was co-transformed with pRS314-PRP16 and pRS315-BRR2 or mutant versions thereof for plasmid shuffle assays. Growth curves were obtained using Sunrise shakers/readers (Tecan). Shortly, overnight cultures (2ml) of W303 brr2Δ/prp16Δ transformed with pRS314-PRP16 or mutants and
